The Company
PathFree Technologies
Building intelligent support for the seconds that matter most.
Introduction
What PathFree is building
PathFree Technologies is developing AI-enabled clinical decision-support technology for Code Blue, CPR, ACLS, and emergency cardiovascular workflows.
Its platform vision brings real-time intelligence, protocol awareness, timing support, clinical workflow guidance, and structured event documentation into one coordinated system.
Clinical Urgency
Emergency teams operate under extreme time pressure and cognitive load.
Intelligent Guidance
AI is designed to support—not replace—the clinician.
Workflow Integration
The platform is intended to fit within existing hospital response environments.
Structured Intelligence
Actions, timing, medication events, and documentation can become part of one coordinated record.
Design Philosophy
Human-Led. AI-Supported.
The clinician leads the resuscitation. The system is intended to stay in a supporting role — surfacing timing, protocol context, and event capture without competing for attention at the bedside.
The Clinical Problem
In cardiac arrest, every second competes with complexity.
Current Environment
Simultaneous demands, fragmented inputs.
- High-pressure Code Blue response
- Multiple disconnected monitors
- Paper or manual protocols
- Medication timing pressure
- Scattered documentation
- Visible cognitive load
Intelligently Supported Environment
One coordinated picture of the event.
- Calm clinical coordination
- Real-time protocol state
- Timing prompts
- Rhythm information
- Medication checks
- Role guidance
- Automated event documentation
Even experienced clinical teams must process rapidly changing patient data, protocol steps, medication timing, equipment readiness, communication, and documentation at the same time.
PathFree is developing technology intended to reduce fragmentation and help clinicians maintain clarity during high-pressure emergency workflows.
Illustrative depiction of intended product concept. Development-stage technology; no clinical outcome, performance, or error-reduction claims are made.
Mission
PathFree Technologies exists to compress the interval between cardiac collapse and clinical-grade intervention — the interval in which survival is decided.
Out-of-hospital cardiac arrest is among the most time-sensitive events in medicine. The clinical response is well understood; the failure is one of interval. Detection is late, response is uneven, and the people first on scene are rarely equipped with the information they need.
PathFree treats that interval as an engineering problem. The company builds the connective layer between the moment of collapse and the moment a clinician takes over: recognition, guidance, coordination, and a structured record of what happened.
The company's work is organized around AIMediQ™ — its emergency response system — and datasyteAI™, the intelligence and data layer beneath it.
Operating Principles
How the company makes decisions
Time is the therapy
Every operating decision at PathFree is measured against a single question: does it remove seconds from the response interval? Product scope, engineering priority, and vendor selection are all filtered through it.
Clinical rigour before commercial velocity
PathFree develops toward regulated clinical pathways. Claims are constrained to what evidence supports, and the roadmap is sequenced around validation, not announcement.
Infrastructure, not applications
The company builds durable layers — device intelligence, triage data, and response coordination — intended to sit beneath many care settings rather than serve a single one.
Discipline in capital
PathFree raises deliberately, in defined tranches, against defined milestones, and communicates the contingency of every forward-looking element.
The Problem
Cardiac arrest is not primarily a treatment problem. It is a timing problem.
Out-of-hospital cardiac arrest remains one of the most lethal medical events precisely because the decisive minutes occur before clinical care arrives. Survival falls sharply with every minute of delay in recognition, response, and defibrillation.
Recognition is delayed
Collapse is frequently unwitnessed, misread, or reported late. The clock begins before anyone realizes the clock has begun.
Response is uneven
Bystander intervention rates vary widely by geography, building type, and time of day. Access to a functioning defibrillator is inconsistent and rarely verified.
Information arrives last
Responding clinicians typically receive the least data at the moment they need the most. Pre-arrival context is fragmented across callers, dispatch, and devices.
Post-event learning is lost
Without a structured data layer, each event teaches the system almost nothing. Response quality does not compound.
PathFree's thesis is that the response interval is addressable with engineering: earlier detection signals, coordinated device readiness, guided intervention, and a data layer that makes each event improve the next.
Development Path
Where the company stands
Formation
PathFree Technologies Corporation established to commercialise emergency cardiac-response technology.
Platform
Development of AIMediQ™, the company's clinical response system, powered by the datasyteAI™ intelligence layer.
Validation
Structured technical validation, clinical advisory formation, and regulatory pathway definition.
Capital
Engagement with Borex Capital and the launch of the PathFree New York Investor Presentation Series.
Statements regarding development stage, plans, and future milestones are forward-looking and are not assurances of outcome.
Regulatory Notice
Development-stage technology. Not for clinical use unless and until applicable regulatory requirements have been satisfied. Final product configuration, intended use, claims, and regulatory pathway remain subject to validation and regulatory review.
Next Step
Confidential materials are provided only after review.
Qualified prospective investors may request the PathFree Technologies information package and details of the New York investor presentation series.